Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy

References

• Vos T, Lim SS, Abbafati Cet al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–1222.
   PubMed Web of Science ®Google Scholar
• World Health Organization.WHO factsheets on Asthma. Available from https://www.who.int/news-room/fact-sheets/detail/asthma. Accessed July 29, 2021.
   Google Scholar
• Pascual RM, Peters SP. Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol. 2005;116(3):477–486;quiz 487. doi:10.1016/j.jaci.2005.07.011
   Web of Science ®Google Scholar
• Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11(1):54–61. doi:10.1111/j.1440-1843.2006.00784.x
   PubMed Web of Science ®Google Scholar
• Hancox RJ, Cowan DC, Aldridge RE, et al. Asthma phenotypes: consistency of classification using induced sputum. Respirology. 2012;17(3):461–466. doi:10.1111/j.1440-1843.2011.02113.x
   PubMed Web of Science ®Google Scholar
• Douwes J. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002;57(7):643–648. doi:10.1136/thorax.57.7.643
   PubMed Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JR, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–373. doi:10.1183/09031936.00202013
   PubMed Web of Science ®Google Scholar
• Wenzel S. Severe asthma: epidemiology, pathophysiology and treatment. Mt Sinai J Med. 2003;70:185–190.
   PubMed Web of Science ®Google Scholar
• Engelkes M, de Ridder MAJ, Svensson E, et al. Multinational, database cohort study to assess severe exacerbation rate in asthma. Respir Med. 2020;165:105919. doi:10.1016/j.rmed.2020.105919
   Web of Science ®Google Scholar
• Bel EH, Sousa A, Fleming L, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the innovative medicine initiative (IMI). Thorax. 2011;66(10):910–917. doi:10.1136/thx.2010.153643
   PubMed Web of Science ®Google Scholar
• Chanez P, Wenzel SE, Anderson GP, et al. Severe asthma in adults: what are the important questions? J Allergy Clin Immunol. 2007;119(6):1337–1348. doi:10.1016/j.jaci.2006.11.702
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Difficult-to-treat & severe asthma in adolescent and adult patients. diagnosis and management. A GINA pocket guide for health professionals; 2018. Available from: https://ginasthma.org/wp-content/uploads/2018/11/GINA-SA-FINAL-wms.pdf. Accessed July 29, 2021.
   Google Scholar
• Hekking PP, Wener RR, Amelink M, et al. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135:896–902. doi:10.1016/j.jaci.2014.08.042
   PubMed Web of Science ®Google Scholar
• Sadatsafavi M, Lynd L, Marra C, et al. Direct health care costs associated with asthma in British Columbia. Can Respir J. 2010;17:74–80. doi:10.1155/2010/361071
   PubMed Web of Science ®Google Scholar
• Braido F, Brusselle G, Guastalla D, et al. Determinants and impact of suboptimal asthma control in Europe: the international cross-sectional and longitudinal assessment on asthma control (LIAISON) study. Respir Res. 2016;17(1):51. doi:10.1186/s12931-016-0374-z
   PubMed Web of Science ®Google Scholar
• Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med. 2004;170:836–844. doi:10.1164/rccm.200401-033OC
   PubMed Web of Science ®Google Scholar
• Gauthier M, Ray A, Wenzel SE. Evolving concepts of asthma. Am J Respir Crit Care Med. 2015;192(6):660–668. doi:10.1164/rccm.201504-0763PP
   PubMed Web of Science ®Google Scholar
• Allegra L, Cremonesi G, Girbino G, et al; PRISMA (PRospectIve Study on asthMA control) Study Group. Real-life prospective study on asthma control in Italy: cross-sectional phase results. Respir Med. 2012;106:205–214. doi:10.1016/j.rmed.2011.10.001
   PubMed Web of Science ®Google Scholar
• Bettoncelli G, Magnoni MS, Fassari C, et al. Il controllo dell’asma in Italia misurato con ACT (Asthma Control Test). Società Italiana di Medicina Generale. 2006;6:10–17.
   Google Scholar
• Vianello A, Caminati M, Andretta M, et al. Prevalence of severe asthma according to the drug regulatory agency perspective: an Italian experience. World Allergy Organ J. 2019;12(4):100032. doi:10.1016/j.waojou.2019.100032
   PubMed Web of Science ®Google Scholar
• Pedrini A, Rossi E, Calabria S, et al. Current management of severe refractory asthma in Italy: analysis of real-world data. Glob Reg Health Technol Assess. 2017;4(1):e216–e220. doi:10.5301/grhta.5000273
   Web of Science ®Google Scholar
• Accordini S, Bugiani M, Arossa W, et al. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol. 2006;141(2):189–198. doi:10.1159/000094898
   PubMed Web of Science ®Google Scholar
• Poddighe D, Brambilla I, Licari A, Marseglia GL. Pediatric rhinosinusitis and asthma. Respir Med. 2018;141:94–99. PMID: 30053979. doi:10.1016/j.rmed.2018.06.016
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Duh MS, Lafeuille MH, et al. Acute and chronic systemic corticosteroid-related complications in patients with severe asthma. J Allergy Clin Immunol. 2015;136(6):1488–1495. doi:10.1016/j.jaci.2015.07.046
   Google Scholar
• Lefebvre P, Duh MS, Lafeuille MH, et al. Acute and chronic systemic corticosteroid-related complications in patients with severe asthma. J Allergy Clin Immunol. 2015;136(6):1488–1495. doi:10.1016/j.jaci.2015.07.046
   PubMed Web of Science ®Google Scholar
• Foster JM, McDonald VM, Guo M, Reddel HK. “I have lost in every facet of my life”: the hidden burden of severe asthma. Eur Respir J. 2017;50(3):1700765. doi:10.1183/13993003.00765-2017
   PubMed Web of Science ®Google Scholar
• Waljee AK, Rogers MAM, Paul L, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415. doi:10.1136/bmj.j1415
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma.Difficult-to-treat & severe asthma in adolescent and adult patients. diagnosis and management. A GINA pocket guide for health professionals; 2018. Available from https://ginasthma.org/wp-content/uploads/2018/11/GINA-SA-FINAL-wms.pdf. Accessed July 29, 2021.
   Google Scholar
• Colombo GL, Di Matteo S, Heffler E, et al. Risultati dello studio HERCULES: valutazione economica dell’impiego di risorse sanitarie e descrizione del profilo clinico del paziente con asma grave non controllato in Italia secondo dati di real-world. [Results of the HERCULES study: economic evaluation of healthcare resources use and description of the clinical profile of the patient with severe uncontrolled asthma in Italy according to real-world data]. Clin Econ Italian Articles Outcomes Res. 2020;15:63–78. Italian.
   Google Scholar
• Canonica GW, Colombo GL, Bruno GM, et al. Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the severe asthma network in Italy (SANI) registry. World Allergy Organ J. 2019;12(1):100007. doi:10.1016/j.waojou.2018.12.001
   PubMed Web of Science ®Google Scholar